VCM
XERS icon

Versant Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Versant Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64K Buy
207
+158
+322% +$1.01K ﹤0.01% 2585
2026
Q1 		$284 Buy
+49
New +$325 ﹤0.01% 2749

Other funds holding XERS

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Versant Capital Management's XERS Position: Q2 2026 in Review

Versant Capital Management increased its Xeris Biopharma Holdings (XERS) stake by 322% in Q2 2026, buying an estimated $1.01K and bringing the position to 207 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

Versant Capital Management first reported a position in XERS in Q1 2026 and has held it in 2 quarters since. 25 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Versant Capital Management held 207 shares of Xeris Biopharma Holdings worth $1.64K as of Q2 2026.
  • Versant Capital Management bought 158 Xeris Biopharma Holdings shares in Q2 2026, an estimated $1.01K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2585 holding.
  • Versant Capital Management first reported a position in Xeris Biopharma Holdings in Q1 2026 and has held it in 2 quarters since.
  • 25 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.